default author photo

Yiyuan Zhang

University of Oxford

SCHOLARLY PAPERS

3

DOWNLOADS

354

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

The Effect of Pneumococcal Vaccines on Nasopharyngeal Colonisation Following Human Infection Challenge with Serotype 3 and Serotype 6b

Number of pages: 27 Posted: 16 Jul 2024
Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Malawi - Malawi-Liverpool-Wellcome Trust Clinical Research Programme, University of Liverpool - School of Tropical Medicine, Imperial College London, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Wolverhampton, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, Liverpool School of Tropical Medicine, University of Oxford, Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer Pharma GmbH, Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer, Inc., Pfizer, Inc., Pfizer, Inc. - Vaccines Medical Development & Scientific Affairs, Pfizer Inc. - Medical and Scientific Affairs, Liverpool School of Tropical Medicine - Department of Clinical Sciences, Liverpool School of Tropical Medicine and Independent
Downloads 170 (442,467)

Abstract:

Loading...

Infectious Diseases, Streptococcus pneumoniae, Pneumococcus, PCV13, Pneumococcal Conjugate Vaccine, PPV23, Pneumococcal polysaccharide vaccine, Serotype 3, Pneumococcal Colonisation, Immunity

2.

Five-Year Vaccine Protection Following a Single Dose of Vi-Tetanus Toxoid Conjugate Vaccine in Bangladeshi Children: A Cluster Randomised Trial

Number of pages: 27 Posted: 01 May 2024
- Infectious Disease Division, International Centre for Diarrheal Disease Research (icddr,b), University of Oxford, International Centre for Diarrheal Disease Research (icddr,b), University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford, International Centre for Diarrheal Disease Research (icddr,b), International Centre for Diarrheal Disease Research (icddr,b), International Centre for Diarrheal Disease Research (icddr,b), International Centre for Diarrheal Disease Research (icddr,b), International Centre for Diarrheal Disease Research (icddr,b), Yale University - Institute for Global Health, International Vaccine Institute, University of Oxford - Oxford Vaccine Group and University of Oxford - Centre for Vaccinology and Tropical Medicine
Downloads 104 (669,616)

Abstract:

Loading...

TCV, typhoid conjugate vaccine, protection, vaccine effectiveness, medium term, typhoid

3.

Covid-19 Vaccine Effectiveness and Sars-Cov-2 Variants in Nepal: Test-Negative Case-Control Study and Genetic Sequencing (Covvar Nepal)

Number of pages: 29 Posted: 23 Jul 2025
Patan Academy of Health Sciences, Patan Academy of Health Sciences, University of Oxford, Patan Academy of Health Sciences, The University of Sydney - Westmead Hospital, University of Oxford - Big Data Institute, University of Oxford, University of Oxford, University of Oxford, Patan Academy of Health Sciences, Patan Academy of Health Sciences, Patan Academy of Health Sciences, Patan Academy of Health Sciences, University of Oxford, University of Oxford, Patan Academy of Health Sciences, Patan Academy of Health Sciences, Patan Academy of Health Sciences, Patan Academy of Health Sciences, Patan Academy of Health Sciences, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Patan Academy of Health Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Oxford Vaccine Group and Patan Academy of Health Sciences
Downloads 80 (803,225)

Abstract:

Loading...

vaccine, COVID-19, effectiveness, Nepal, "test-negatuve case-control"